June, 2016

The Rapidly Changing Access Landscape

How will the access landscape change over the next three years?

June, 2016

SIX COMPANIES EFFECTIVELY PARTNER WITH CONTRACTING DECISION MAKERS

AstraZeneca, BI, J&J HCS, Merck, Novartis, and Novo Nordisk achieve high marks in new report

May, 2016

Payer Tactics to Manage Multiple Sclerosis Agents

How will payer management of the multiple sclerosis category evolve in the next few years?

May, 2016

More Pathway Programs Expand to Include Complete Networks of Plan Oncologists

What is the current and future implementation of oncology pathways by cancer type?

May, 2016

Relationships with Contracting Decision Makers

Where do relationships stand with contracting decision makers?

May, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW RESEARCH BULLETIN BOARD: THE IMPACT OF BIOSIMILAR DRUGS ON MARKET ACCESS

Health Strategies Group has announced the launch of a new turnkey research focused on the impact of biosimilars on market access.

May, 2016

Medicare Stakeholders Implement Several Strategies to Manage Policy Changes

What business strategies are Medicare stakeholders developing to address Medicare policy changes?

May, 2016

Contracting Barriers for Psoriasis Brands

How does my psoriasis brand’s contract structure compare to key competitors?

May, 2016

Opportunities Exist to Increase Value with Asthma Program Offers to Health Plans

Which asthma programs and resources do health plans value most?

April, 2016

Specialty Pharmacy: The Dominant Distribution Channel of Choice for Plans

How do specialty pharmacies and specialty distributors influence the management of specialty products?

Pages

Subscribe to RSS - blamb@healthstrategies.com's blog

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.